MedPath
NMPA Approval

硫酸西索米星

国药准字H20053239

September 5, 2024

Drug Information

硫酸西索米星

原料药

化学药品

September 5, 2024

Company Information

Applicant Company

福州市台江区祥坂路138号

Manufacturing Company

福州市台江区祥坂路138号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

硫酸西索米星 - NMPA 批准文号 | MedPath